Medica Sur SA de CV Class B

Medica Sur SA de CV Class B

52.50
MXN
-3.50
(-6.25%)
4.14EPS
7.53P/E
3.24BMarket Cap
Dec 02Next Earn
Medica Sur SA de CV Class B
BIVA:MEDICA/B
(Institutional Stock Exchange)

Recent

price

52.50

P/E

ratio

7.53

div

yld

2.56%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
MXN
15.52
16
16.95
18.3
18.59
18.48
20.36
27.83
29.26
22.29
25.49
30.92
35.83
38.26
41.02
44.32
42.37
Revenue per Share
1.97
1.96
2.44
3.08
2.83
1.96
1.16
1.88
1.27
1.14
4.53
9.36
8.8
5.88
4.3
5
4.51
Basic EPS, GAAP
1.86
2.21
0.88
2.25
1.28
0.81
-0.26
-0.42
1.02
3.63
7.89
5.44
0.7
2
4.9
7.43
5.45
Free Cash Flow per Basic Share
0.55
0.53
0.55
1.54
0.07
0.82
0.65
0.67
0.59
0.01
- -
1.31
27.98
6.11
1.41
1.36
1.34
Dividend per Share
17.46
19.11
20.99
22.36
25.2
26.3
26.79
27.95
28.73
29.87
32.51
39.85
23.36
21.27
24.56
27.61
26.05
Book Value per Share
15.42
17.29
19.17
20.55
23.38
24.49
14.08
15.44
16.37
18.58
21.34
38.85
22.22
19.98
23.27
26.04
24.4
Tangible Book Value per Share
117
120
123
123
123
123
123
123
123
123
123
123
108
108
107
108
107
Basic Weighted Avg Shares
1,823
1,925
2,090
2,256
2,292
2,279
2,510
3,431
3,608
2,748
3,143
3,812
3,868
4,130
4,403
4,789
4,528
Sales/Revenue/Turnover
19.63
18.32
20.01
22.52
20.38
15.21
7.78
13.84
10.11
12.99
20.32
19.59
14.86
14.31
12.9
16.76
13.1
Operating Margin (%)
120
130
106
110
117
122
325
220
221
158
324
177
169
179
194
200
199
Depreciation Expense
231
236
301
380
349
241
143
232
156
141
559
1,155
950
635
462
540
482
Net Income, GAAP
32.24
28
28.06
24.6
26.19
31.03
26.58
31.97
40.77
24.49
29.96
41.71
30.22
24.76
28.89
32.61
29.58
Effective Tax Rate (%)
12.69
12.24
14.38
16.83
15.23
10.58
5.68
6.76
4.33
5.12
17.78
30.28
24.56
15.38
10.48
11.28
10.64
Profit Margin (%)
29
-76
-23
54
182
204
257
386
243
80
655
3,129
688
233
-444
711
-323
Working Capital
389
3
- -
- -
- -
- -
1,284
1,351
1,088
1,114
1,196
1,035
1,023
1,008
12
1,003
12
LT Debt
2,051
2,356
2,588
2,758
3,107
3,243
3,308
3,447
3,543
3,682
4,009
4,914
2,522
2,037
2,344
2,523
2,486
Total Equity
9.94
8.47
9.83
12.61
10.89
6.82
3.84
7.02
4.66
5.32
7.73
6.15
7.69
15.08
11.23
14.28
12.1
Return on Invested Capital (%)
9.83
9.23
11.09
13.85
11.9
7.59
4.04
6.95
5.09
4.87
12.22
21.22
21.01
20.89
16.01
17.72
15.98
Return on Capital (%)
12.29
10.69
12.16
14.21
11.91
7.59
4.36
6.87
4.47
3.89
14.54
25.88
25.55
27.87
21.08
22.21
20.76
Return on Common Equity (%)

Capital Structure

MXN

•

in mil. unless spec.
Sep'24
Dec'24
Mar'25
ST Debt
1,014
1,014
1,015
LT Borrowings
- -
- -
- -
LT Finance Leases
7
12
12
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
96
95
95
Market Capitalization
2,681
3,108
3,239

Working Capital

MXN

•

in mil. unless spec.
Sep'24
Dec'24
Mar'25
Total Current Assets
1,463
1,558
1,765
Cash, Cash Equivalents & STI
974
1,122
1,315
Accounts Receivable, Net
339
263
309
Inventories
116
113
109
Total Current Liabilities
2,079
2,002
2,088
Payables & Accruals
- -
- -
- -
ST Debt
1,014
1,014
1,015
Deferred Revenue
- -
- -
- -

Growth Rates

MXN

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.09%
-4.53%
7.62%
Free Cash Flow
22.6%
52.27%
52.69%
Net Income, GAAP
32.21%
9.09%
17.06%
Sales/Revenue/Turnover
8.74%
8.98%
8.77%
Total Cash Common Dividend
8,833.57%
17,709.61%
-2.7%

Quarterly Revenue

MXN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,080
1,074
1,117
1,132
4,403
2025
1,205
- -
- -
1,223
4,789
2026
1,195
1,144
- -
- -
- -

Quarterly Earnings Per Share

MXN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.1
0.8
1.1
1.3
4.3
2025
1.3
- -
- -
1.3
5
2026
1.2
1.1
- -
- -
- -

Quarterly Dividends Per Share

MXN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
1.33
0.03
0.03
1.41
2025
- -
- -
- -
0.01
1.36
2026
- -
1.32
- -
- -
- -
Business
Médica Sur, S.A.B. de C.V. (MEDICAB.MX) operates as a leading healthcare provider in Mexico, managing specialty hospitals, emergency and diagnostic centers, medical laboratories, organ and blood banks, and accommodation facilities. The company offers a comprehensive range of medical services including angiology, vascular and endovascular surgery; bariatric surgery; cancer treatment; cardiology; checkups and preventive medicine; pediatrics; dentistry; emergency care; endocrinology; gastroenterology, hepatology and endoscopy; general surgery; geriatrics; gynecology and obstetrics; specialized surgery; neonatology; neurology, neurosurgery and gamma knife radiosurgery; neurophysiology; nuclear medicine; orthopedics and traumatology; outpatient surgery; plastic surgery; robotic surgery; spine microsurgery; transplants; urology; vascular disease treatments; imaging and MRI services; anatomic pathology; oncology; ophthalmology; otolaryngology; radiology; and radiosurgery. Additional offerings encompass accommodation; concierge services; digital hospital and telemedicine; gourmet dining; assistance with insurance paperwork; medical tourism; tours and transportation; and pharmaceutical distribution. Founded in 1981 and headquartered in Mexico City at Puente de Piedra No. 150, Toriello Guerra, Tlalpan, the company serves patients through its flagship 190-bed facility featuring 15 operating rooms, 15 intensive care units, 13 adult emergency units, three pediatric emergency cubicles, one orthopedic emergency unit, and 542 medical offices across three towers. Specialized centers include the Integral Oncology Center with radiotherapy; Center for Neurology and Neurosurgery; Gastroenterology; Urology; Hemodynamics; Hemodialysis; Positron Emission Tomography; Comprehensive Diagnostic Center; and advanced imaging with tomography, magnetic resonance, and PET-CT. Médica Sur targets private patients, insured individuals, and international medical tourists, primarily in Mexico with a focus on high-complexity care, and operates through subsidiaries such as Corporacion de Atencion Medica SA de CV, El Portal Medico SA de CV, Servicios de Administracion Hospitalaria SA de CV, and Telemed SA de CV; it is a subsidiary of Neuco SAPI de CV and a member of the Mayo Clinic Care Network since 2014, marking its 10th anniversary in 2024 with enhanced collaboration including a Mayo Clinic patient information office opened in 2018. In recent developments, the company has maintained strategic stability with no major acquisitions or funding rounds reported in 2024-2025, instead focusing on operational enhancements such as ongoing equipment modernization including Pentero 900 microscopes, 4K laparoscopy towers, Lasik devices, cardiovascular systems, robotic clinical analyzers, OPMI Lumera 700 microscopes, and PET-CT upgrades. It continues to prioritize teaching, training for young doctors, and scientific publications while upholding JCI accreditation and top rankings as Mexico's leading hospital per America Economia. Geographic operations remain centered in Mexico City, serving national and international patients through its integrated healthcare model.